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Surgical TechniquesTrans-semilunar valve hybrid technique for Amplatzer device closure
of complex muscular ventricular septal defects during arterial
switch operationSurendranath R. Veeram Reddy, MD, Javier E. Brenes, MD, and Joseph M. Forbess, MD, Dallas, TexMultiple muscular ventricular septal defects (mVSDs) in
patients with d-transposition of the great arteries (dTGA)
present a unique challenge. In neonates with dTGA and
remote mVSDs not suitable for patch closure, various
single-stage or staged treatment strategies are used. We
present a neonate with dTGA and complex multiple mVSDs
who underwent a novel single-stage trans-semilunar valve
hybrid technique for device closure of multiple mVSDs fol-
lowed by the arterial switch operation.
CLINICAL SUMMARY
An 11-day-old neonate with dTGA and multiple mVSDs
was taken to the operating room for a single-stage hybrid
procedure: intraoperative device closure of mVSDs and
arterial switch operation. Echocardiography showed com-
plex mVSDs with 1 large apical mVSD and an adjacent
additional tunnel-like apical mVSD at the left ventricular
(LV) apex with multiple openings on the right ventricle
(RV) side caused by dense RV muscle trabeculations
(Figure 1).
TECHNIQUE
On cardiopulmonary bypass (CPB), the patent ductus
arteriosus was ligated and divided. An attempt to visualize
the apical mVSDs via a right atriotomy was unsuccessful.
After transection of the great vessels, the ventricular sep-
tum was visualized from the anterior (aortic) and posterior
(pulmonary) semilunar valves. A large tunnel-shaped
opening of the mVSD was best seen from the anterior
semilunar valve. A right-angle clamp, advanced from
the anterior semilunar valve across the mVSD into the
LV, was used to snare a soft-tip wire, advanced from the
posterior semilunar valve to the LV. The wire was exteri-
orized across the anterior semilunar valve (Figure 2, B)From the University of Texas Southwestern Medical Center, Dallas, Tex.
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cured in the LV apex with a forcep from the posterior
semilunar valve. A 7F sheath was advanced from the an-
terior semilunar valve, across the mVSD tunnel to the LV
apex. The tip of the sheath was gently secured in place
with a forcep from the posterior semilunar valve. An 8/6
Amplatzer Duct Occluder (ADO; St Jude Medical, Inc,
St Paul, Minn) was advanced through the short sheath to
the LV apex. The aortic retention skirt (12 mm in diame-
ter) was deployed on the LV side under direct vision
without capturing the mitral valve apparatus (Figure 2,
C). The sheath was gently pulled against the septum,
and the device was deployed across the mVSD. Attention
was then directed through the anterior semilunar valve,
and the ADO device was seen wedged in the mVSD tun-
nel on the RV aspect. The device was released, and by
working through the tricuspid valve, a single suture was
placed to secure the device to the RV septum (Figure 2,
D). The tricuspid and mitral valves were undisturbed,
and the semilunar valves were well preserved. Next, an ar-
terial switch procedure and a Lecompte maneuver were
performed. A postoperative echocardiogram showed sta-
ble device position with no residual ventricular septal
defect shunt (Figure 1, C).DISCUSSION
Successful closure of complex mVSDs is a surgical
challenge. Device closure of mVSDs has been increas-
ingly proposed as a viable alternative to conventional tech-
niques. Multiple authors have published their experience
with staged treatment strategies for device closure of
mVSDs in patients with dTGA.1-3 Neukamm and
colleagues4 described a hybrid transatrial strategy for de-
vice closure of mVSDs with an ADO. Baird and col-
leagues5 described the superior left atrial hybrid
approach under CPB for closure of mVSDs with the
ADO device in a patient with dTGA. To our knowledge,
the trans-semilunar valve hybrid surgical technique for de-
vice closure of complex multiple apical mVSDs with an
ADO has never been described. This approach may be
beneficial in patients with a complex tunnel-like mVSD,
from the LV apex extending anteriorly to the RV infundib-
ulum, who require open surgery for associated heart
defects. The advantages of the trans-semilunar valverdiovascular Surgery c Volume 146, Number 2 483
FIGURE 1. Complex apical mVSDs shown in different echocardiogram projections. Row 1: parasternal long-axis view: complex apical mVSD
without color (A), with color (B), and after device closure (C). Row 2: parasternal short-axis view: complex apical mVSD without color (A), with
color (B), and after device closure (C). Row 3: apical 4-chamber view: complex apical mVSD without color (A), with color (B), and after device
closure (C).
Surgical Techniqueshybrid approach for mVSD device closure include avoid-
ance of left atriotomy, right or left ventriculotomy, and any
associated muscle resection. The disadvantage of needing
a sternotomy and CPB with this approach does not apply
to patients who require open surgery to correct other asso-
ciated heart defects.CONCLUSIONS
Selecting the appropriate size and type of device is an
important step in this hybrid strategy. The patent ductus
arteriosus ADO devices appear to be an optimal anatomic484 The Journal of Thoracic and Cardiovascular Surgmatch for the tunnel-like apical mVSDs. The relatively
larger aortic retention skirt of the ADO devices also offers
an additional advantage of occluding other adjacent
smaller mVSDs. The authors emphasize the importance
of preoperative imaging for accurate delineation of the lo-
cation, number, shape, and size of the mVSDs and clear
appreciation of understanding the adjacent anatomy and
proposed repair of the associated heart defects. This hy-
brid strategy also highlights the importance of collabora-
tion between cardiothoracic surgeons and interventional
cardiologists in the management of such challenging heart
defects.ery c August 2013
FIGURE 2. Trans-semilunar valve hybrid surgical technique for device closure of complex apical mVSDs. A, Transposed great arteries and complex apical
mVSDs. B, Right angle clamp across the mVSD to snare a soft tip wire. C, Partially deployed ductal occluder device across the mVSD. D, Released ductal
occluder device wedged in the mVSD and secured by a pledgeted suture.
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